Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
Clinical trial NCT01035671 · COMPLETED
Trial details
- NCT number
- NCT01035671
- Sponsor
- Penwest Pharmaceuticals Co.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.